Hochdosistherapie mit Dopaminagonisten

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Akt Neurol

• Publication date

  2001-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1055/s-2001-18913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose therapy with ropinirole in patients with Parkinson's disease

  2001cited by this paper
• A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

  2000cited by this paper
• The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

  1998cited by this paper
• Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa.

  1997cited by this paper
• Ropinirole for the treatment of early Parkinson's disease

  1997cited by this paper
• High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias

  1996cited by this paper
• Early development of levodopa‐induced dyskinesias and response fluctuations in young‐onset Parkinson's disease

  1991cited by this paper
• Levodopa‐induced dyskinesia

  1990cited by this paper
• Motor complications associated with chronic levodopa therapy in Parkinson's disease.

  1989cited by this paper
• Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems.

  1987cited by this paper

• No citing papers are available for this paper.